Commentary: Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders

Medical and Pediatric Oncology

Volumn 35, Issue 4, 2000, Pages 426-427

  Maarten Egeler, R ^a   Willman, Cheryl L ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CELL INFILTRATION; CHROMOSOME 7; CHROMOSOME TRANSLOCATION; COMORBIDITY; CYTOGENETICS; CYTOKINE RELEASE; DENDRITE; DISEASE ASSOCIATION; HISTIOCYTOSIS X; HUMAN; MYELODYSPLASIA; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STEM CELL; CHILD; DENDRITIC CELL; GENETICS; NEURAL TUBE DEFECT; PATHOLOGY;

CHILD; DENDRITIC CELLS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; NEURAL TUBE DEFECTS;

EID: 0034294789     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911x(20001001)35:4<426::aid-mpo6>3.0.co;2-%23     Document Type: Note

References (7)

1. Differential in situ cytokine profiles of Langerhans-like cells and T-cells in Langerhans cell histiocytosis: Abundant expression of cytokines relevant to disease and treatment
2. Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease
3. Familial clustering of Langerhans cell histiocytosis
4. Concurrent Langerhans cell histiocytosis and myelodysplasia in children
5. p53 Expression in Langerhans cell histiocytosis
6. Cytogenetic abnormalities in Langerhans cell histiocytosis
7. Haploinsufficiency of CBFA2 (AML1) causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia (FDP/AML)